C-reactive protein (CRP) contributes to the development of AKI by binding to its receptors, CD32 and CD64, which subsequently activate signaling pathways such as nuclear factor-kappa B (NF-κB) and transforming growth factor-beta (TGF-β)/Smad3 [33]. This evidence concerns the gene FCGR1A and acute kidney injury.